Remember: GLP-1s dont cause muscle loss directlyits the caloric deficit that does
In return for the license, Ascendis will be eligible to receive total payments of up to $285 million in upfront, development, and regulatory milestone payments for the lead program
Nine manufacturers Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis, and Sanofi agreed to reduce prices on drugs that treat type two diabetes, rheumatoid arthritis, multiple sclerosis, asthma, COPD, hepatitis B and C, HIV, and certain cancers, providing every State Medicaid program access to MFN drug prices
BPC-157 is not effective when healing fully torn ligaments/tendons, but aids the recovery time after surgical intervention
In contrast, injections can show results in just a few days